Quantumzyme Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTZM research report →
Price Chart
About the company
Quantumzyme Corp. is a biotransformation firm specializing in the creation of engineered enzymes, primarily utilized for the production of active pharmaceutical ingredients (APIs). Established in 2015, the company was formerly known as Reliant Services, Inc.
- CEO
- Naveen Krishnarao Kulkarni
- IPO
- 2024
- Employees
- 1
- HQ
- San Diego, CA, US
Get TickerSpark's AI analysis on QTZM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $31.17M
- P/E
- -6.46
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -63.76
- EV/EBITDA
- -261.59
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 997.31%
- ROIC
- 62.54%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-180,537
- Net Income
- $-199,269+0.0%
- EPS
- $-0.01+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $5.04
- 52W Low
- $0.00
- 50D MA
- $2.67
- 200D MA
- $1.04
- Beta
- 7.51
- RSI (14)
- 42
- Avg Volume
- 79.68K
No earnings-call transcripts are available for QTZM yet.
- Free Float
- 48.2%
- Shares Outstanding
- 38.96M
- Float Shares
- 18.76M
Our QTZM coverage
Recent articles, reports, and earnings notes.
No research on QTZM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QTZM report →